Ketolide antimicrobial activity persists after disruption of interactions with domain II of 23S rRNA

Antimicrobial Agents and Chemotherapy
Guy W NovotnyStephen Douthwaite

Abstract

Ketolides are the latest derivatives developed from the macrolide erythromycin to improve antimicrobial activity. All macrolides and ketolides bind to the 50S ribosomal subunit, where they come into contact with adenosine 2058 (A2058) within domain V of the 23S rRNA and block protein synthesis. An additional interaction at nucleotide A752 in the rRNA domain II is made via the synthetic carbamate-alkyl-aryl substituent in the ketolides HMR3647 (telithromycin) and HMR3004, and this interaction contributes to their improved activities. Only a few macrolides, including tylosin, come into contact with domain II of the rRNA and do so via interactions with nucleotides G748 and A752. We have disrupted these macrolide-ketolide interaction sites in the rRNA to assess their relative importance for binding. Base substitutions at A752 were shown to confer low levels of resistance to telithromycin but not to HMR3004, while deletion of A752 confers low levels of resistance to both ketolides. Mutations at position 748 confer no resistance. Substitution of guanine at A2058 gives rise to the MLS(B) (macrolide, lincosamide, and streptogramin B) phenotype, which confers resistance to all the drugs. However, resistance to ketolides was abolished wh...Continue Reading

References

Jan 1, 1979·Molecular Biology, Biochemistry, and Biophysics·D Vázquez
Jan 1, 1988·Methods in Enzymology·C D SigmundE A Morgan
Dec 1, 1967·Proceedings of the National Academy of Sciences of the United States of America·M Sekiguchi, S Iida
Jun 11, 1984·Nucleic Acids Research·C D SigmundE A Morgan
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·B Weisblum
Jan 1, 1997·Annual Review of Biochemistry·R Green, H F Noller
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·T AsaiC L Squires
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·B Vester, S Douthwaite
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·I OdenholtO Cars
Apr 3, 2001·Science·M M YusupovH F Noller
Apr 4, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A Bryskier
Sep 22, 2001·The Journal of Antimicrobial Chemotherapy·R Leclercq
May 23, 2002·Antimicrobial Agents and Chemotherapy·Mingfu Liu, Stephen Douthwaite
Aug 2, 2002·Molecular Cell·Jeffrey L HansenThomas A Steitz
Nov 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Mingfu Liu, Stephen Douthwaite
Jul 3, 2003·Journal of Bacteriology·Rita BerisioAda Yonath

❮ Previous
Next ❯

Citations

Nov 2, 2005·Nature Reviews. Microbiology·Jacob Poehlsgaard, Stephen Douthwaite
Sep 30, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jack A DunkleJamie H D Cate
Mar 1, 2012·Nucleic Acids Research·Ourania N KostopoulouDimitrios L Kalpaxis
Sep 22, 2010·Antimicrobial Agents and Chemotherapy·Beatriz Llano-SoteloAlexander S Mankin
Aug 29, 2012·Antimicrobial Agents and Chemotherapy·Niels Møller AndersenStephen Douthwaite
Jun 21, 2005·Emerging Infectious Diseases·Surbhi Malhotra-KumarHerman Goossens
Mar 30, 2005·Proceedings of the National Academy of Sciences of the United States of America·Peter PfisterErik C Böttger
Jan 8, 2014·Veterinary Microbiology·Uri LernerInna Lysnyansky
Oct 28, 2016·Critical Reviews in Microbiology·Cláudia GomesJoaquim Ruiz
Jul 12, 2005·The Journal of Antimicrobial Chemotherapy·Tamiko HisanagaGeorge G Zhanel
Apr 27, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Nishaminy Kasbekar, Pinak S Acharya
Feb 6, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Dima KhalilFlorence Tardy
Dec 3, 2020·International Journal of Antimicrobial Agents·Olga A ChernovaRustam I Aminov
Jun 20, 2020·The Veterinary Journal·Dominiek MaesAnne V Gautier-Bouchardon
Mar 23, 2021·Cellular and Molecular Life Sciences : CMLS·Patrícia Martins-Dias, Luísa Romão
Jul 14, 2018·Microbiology Spectrum·Anne V Gautier-Bouchardon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.